Vorinostat synergizes with ridaforolimus and abrogates the ridaforolimus-induced activation of AKT in synovial sarcoma cells

Por Morgan, Sherif S, Cranmer, Lee D
Publicado no BMC Res Notes (2014)

Treatment of Unresectable and Metastatic Cutaneous Squamous Cell Carcinoma

Por Cranmer, Lee D., Engelhardt, Candace, Morgan, Sherif S.
Publicado em 2010

In Vivo Replication, Latency, and Immunogenicity of Murine Cytomegalovirus Mutants with Deletions in the M83 and M84 Genes, the Putative Homologs of Human Cytomegalovirus pp65 (U...

Por Morello, Christopher S., Cranmer, Lee D., Spector, Deborah H.
Publicado em 1999

Suppression of Murine Cytomegalovirus (MCMV) Replication with a DNA Vaccine Encoding MCMV M84 (a Homolog of Human Cytomegalovirus pp65)

Por Morello, Christopher S., Cranmer, Lee D., Spector, Deborah H.
Publicado em 2000

Serum protein acidic and rich in cysteine (SPARC) as a prognostic marker in soft tissue sarcomas

Por Morgan, Sherif S, Nagle, Raymond B, Cranmer, Lee D
Publicado em 2014

Pazopanib in the management of advanced soft tissue sarcomas

Por Cranmer, Lee D, Loggers, Elizabeth T, Pollack, Seth M
Publicado no Ther Clin Risk Manag (2016)

Ipilimumab Pharmacotherapy in Patients with Metastatic Melanoma

Por Jeter, Joanne M., Cranmer, Lee D., Hersh, Evan M.
Publicado em 2012

Targeting gastrointestinal stromal tumors: the role of regorafenib

Por Schroeder, Brett, Li, Zula, Cranmer, Lee D, Jones, Robin L, Pollack, Seth M
Publicado no Onco Targets Ther (2016)

Radiation-Induced Sarcoma of the Breast: A Systematic Review

Por Sheth, Grishma R., Cranmer, Lee D., Smith, Benjamin D., Grasso-LeBeau, Lauren, Lang, Julie E.
Publicado em 2012

A Phase 1 Study of a Vaccine Targeting Preferentially Expressed Antigen in Melanoma and Prostate-specific Membrane Antigen in Patients With Advanced Solid Tumors

Por Weber, Jeffrey S., Vogelzang, Nicholas J., Ernstoff, Marc S., Goodman, Oscar B., Cranmer, Lee D., Marshall, John L., Miles, Sabrina, Rosario, Dar, Diamond, David C., Qiu, Zhiyong, Obrocea, Mihail, Bot, Adrian
Publicado em 2011

Phase II Study of the Safety and Antitumor Activity of the Hypoxia-Activated Prodrug TH-302 in Combination With Doxorubicin in Patients With Advanced Soft Tissue Sarcoma

Por Chawla, Sant P., Cranmer, Lee D., Van Tine, Brian A., Reed, Damon R., Okuno, Scott H., Butrynski, James E., Adkins, Douglas R., Hendifar, Andrew E., Kroll, Stew, Ganjoo, Kristen N.
Publicado no J Clin Oncol (2014)

Roles for Endothelin Receptor B and BCL2A1 in Spontaneous CNS Metastasis of Melanoma

Por Cruz-Muñoz, William, Jaramillo, Maria L., Man, Shan, Xu, Ping, Banville, Myriam, Collins, Catherine, Nantel, Andre, Francia, Giulio, Morgan, Sherif S., Cranmer, Lee D., O'Connor-McCourt, Maureen D., Kerbel, Robert S.
Publicado no Cancer Res (2012)

TH-302, a hypoxia-activated prodrug with broad in vivo preclinical combination therapy efficacy: optimization of dosing regimens and schedules

Por Liu, Qian, Sun, Jessica D., Wang, Jingli, Ahluwalia, Dharmendra, Baker, Amanda F., Cranmer, Lee D., Ferraro, Damien, Wang, Yan, Duan, Jian-Xin, Ammons, W. Steve, Curd, John G., Matteucci, Mark D., Hart, Charles P.
Publicado em 2012

A randomized controlled comparison of pembrolizumab and chemotherapy in patients with ipilimumab-refractory melanoma

Por Dummer, Reinhard, Daud, Adil, Puzanov, Igor, Hamid, Omid, Schadendorf, Dirk, Robert, Caroline, Schachter, Jacob, Pavlick, Anna, Gonzalez, Rene, Hodi, F Stephen, Cranmer, Lee D, Blank, Christian, O’Day, Steven J, Ascierto, Paolo A, Salama, April K S, Li, Nicole Xiaoyun, Zhou, Wei, Lis, Joy, Ebbinghaus, Scot, Kang, Peter S, Ribas, Antoni
Publicado no J Transl Med (2015)